Vis enkel innførsel

dc.contributor.authorNichols, Emma
dc.contributor.authorKisa, Adnan
dc.contributor.authorVos, Theo
dc.contributor.authorCollaborators, GBD 2019
dc.contributor.authorKisa, Sezer
dc.contributor.authorMurray, Christopher J L
dc.contributor.authorMokdad, Ali H.
dc.date.accessioned2022-03-10T09:18:14Z
dc.date.available2022-03-10T09:18:14Z
dc.date.created2022-02-13T22:28:58Z
dc.date.issued2021
dc.identifier.citationAlzheimer's and Dementia: Translational Research and Clinical Interventions. 2021, 27 (7), .en_US
dc.identifier.issn2352-8737
dc.identifier.urihttps://hdl.handle.net/11250/2984170
dc.description.abstractIntroduction: Dementia is currently one of the leading causes of mortality globally, and mortality due to dementia will likely increase in the future along with corresponding increases in population growth and population aging. However, large inconsistencies in coding practices in vital registration systems over time and between countries complicate the estimation of global dementia mortality. Methods: We meta-analyzed the excess risk of death in those with dementia and multiplied these estimates by the proportion of dementia deaths occurring in those with severe, end-stage disease to calculate the total number of deaths that could be attributed to dementia. Results: We estimated that there were 1.62 million (95% uncertainty interval [UI]: 0.41–4.21) deaths globally due to dementia in 2019. More dementia deaths occurred in women (1.06 million [0.27–2.71]) than men (0.56 million [0.14–1.51]), largely but not entirely due to the higher life expectancy in women (age-standardized female-tomale ratio 1.19 [1.10–1.26]). Due to population aging, there was a large increase in allage mortality rates from dementia between 1990 and 2019 (100.1% [89.1–117.5]). In 2019, deaths due to dementia ranked seventh globally in all ages and fourth among individuals 70 and older compared to deaths from other diseases estimated in the Global Burden of Disease (GBD) study. Discussion: Mortality due to dementia represents a substantial global burden, and is expected to continue to grow into the future as an older, aging population expands globally.en_US
dc.description.sponsorshipThis work was funded by the Bill and Melinda Gates Foundation, Seattle, WA, and by Gates Ventures, Seattle, WA.en_US
dc.language.isoengen_US
dc.relation.urihttps://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12200
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleGlobal mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019en_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber28en_US
dc.source.volume27en_US
dc.source.journalAlzheimer's and Dementia: Translational Research and Clinical Interventionsen_US
dc.source.issue7en_US
dc.identifier.doi10.1002/trc2.12200
dc.identifier.cristin2001101
dc.relation.projectBill and Melinda Gates Foundationen_US
dc.relation.projectGates Venturesen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal